These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102 [TBL] [Abstract][Full Text] [Related]
3. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R). Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958 [TBL] [Abstract][Full Text] [Related]
4. Investigation of ECD conformational transition mechanism of GLP-1R by molecular dynamics simulations and Markov state model. Zhang J; Bai Q; Pérez-Sánchez H; Shang S; An X; Yao X Phys Chem Chem Phys; 2019 Apr; 21(16):8470-8481. PubMed ID: 30957116 [TBL] [Abstract][Full Text] [Related]
5. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R). Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573 [TBL] [Abstract][Full Text] [Related]
6. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics. Gómez Santiago C; Paci E; Donnelly D Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068 [TBL] [Abstract][Full Text] [Related]
7. Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP. Chepurny OG; Matsoukas MT; Liapakis G; Leech CA; Milliken BT; Doyle RP; Holz GG J Biol Chem; 2019 Mar; 294(10):3514-3531. PubMed ID: 30622136 [TBL] [Abstract][Full Text] [Related]
8. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism. Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000 [TBL] [Abstract][Full Text] [Related]
9. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling. Dods RL; Donnelly D Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711 [TBL] [Abstract][Full Text] [Related]
10. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for Wang H; Hu W; Liu D; Wüthrich K FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025 [TBL] [Abstract][Full Text] [Related]
11. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors. Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600 [TBL] [Abstract][Full Text] [Related]
12. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Song G; Yang D; Wang Y; de Graaf C; Zhou Q; Jiang S; Liu K; Cai X; Dai A; Lin G; Liu D; Wu F; Wu Y; Zhao S; Ye L; Han GW; Lau J; Wu B; Hanson MA; Liu ZJ; Wang MW; Stevens RC Nature; 2017 Jun; 546(7657):312-315. PubMed ID: 28514449 [TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain. West GM; Willard FS; Sloop KW; Showalter AD; Pascal BD; Griffin PR PLoS One; 2014; 9(9):e105683. PubMed ID: 25180755 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study. Redij T; Ma J; Li Z; Hua X; Li Z J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355 [TBL] [Abstract][Full Text] [Related]
16. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Zhang Y; Sun B; Feng D; Hu H; Chu M; Qu Q; Tarrasch JT; Li S; Sun Kobilka T; Kobilka BK; Skiniotis G Nature; 2017 Jun; 546(7657):248-253. PubMed ID: 28538729 [TBL] [Abstract][Full Text] [Related]
17. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology. Willard FS; Ho JD; Sloop KW Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867 [TBL] [Abstract][Full Text] [Related]
18. The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression. Li B; Yang MY; Kim SK; Goddard WA J Am Chem Soc; 2024 Sep; 146(38):26251-26260. PubMed ID: 39266057 [TBL] [Abstract][Full Text] [Related]
19. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon. Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690 [TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor. Johnson RM; Zhang X; Piper SJ; Nettleton TJ; Vandekolk TH; Langmead CJ; Danev R; Sexton PM; Wootten D Biochem Biophys Res Commun; 2021 Nov; 578():84-90. PubMed ID: 34547628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]